11883125falsesale of cosmetic and herbal cannabinoid products2023-04-012024-03-31http://www.companieshouse.gov.uk/2023-03-31http://www.companieshouse.gov.uk/pt:ShareCapital2023-03-31http://www.companieshouse.gov.uk/cd:Director12023-04-012024-03-31http://www.companieshouse.gov.uk/pt:CommercialMotorVehicles2023-03-31http://www.companieshouse.gov.uk/pt:SharePremium2023-03-31http://www.companieshouse.gov.uk/pt:ShareCapital2024-03-31http://www.companieshouse.gov.uk/pt:FurnitureFittings2023-03-31http://www.companieshouse.gov.uk/pt:CommercialMotorVehicles2024-03-31http://www.companieshouse.gov.uk/pt:SharePremium2024-03-31http://www.companieshouse.gov.uk/pt:ToolsEquipment2023-03-31http://www.companieshouse.gov.uk/pt:FurnitureFittings2024-03-31http://www.companieshouse.gov.uk/pt:MotorCars2023-03-31http://www.companieshouse.gov.uk/pt:ToolsEquipment2024-03-31http://www.companieshouse.gov.uk/cd:RegisteredOffice2023-04-012024-03-31http://www.companieshouse.gov.uk/pt:MotorCars2024-03-31http://www.companieshouse.gov.uk/cd:AuditExemptWithAccountantsReport2023-04-012024-03-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2024-03-31http://www.companieshouse.gov.uk/pt:CurrentFinancialInstruments2023-03-31http://www.companieshouse.gov.uk/2023-04-012024-03-31http://www.companieshouse.gov.uk/2023-03-31http://www.companieshouse.gov.uk/cd:FRS1022023-04-012024-03-31http://www.companieshouse.gov.uk/2024-03-31http://www.companieshouse.gov.uk/cd:FullAccounts2023-04-012024-03-31http://www.companieshouse.gov.uk/cd:PrivateLimitedCompanyLtd2023-04-012024-03-31iso4217:GBPxbrli:sharesxbrli:pure
Registered number: 11883125

Healthcare International Research Limited

ACCOUNTS
FOR THE YEAR ENDED 31 MARCH 2024

Prepared By:
Hope Jones
Chartered Accountants
Suite114, Lymington Town Hall
Avenue Road
Lymington
Hants
SO41 9ZG

Healthcare International Research Limited

ACCOUNTS
FOR THE YEAR ENDED 31 MARCH 2024
DIRECTORS
F A Darver
REGISTERED OFFICE
Unit 18 Axis 31, Woolsbridge Industrial
Oakfield Road
Wimborne
Dorset
BH21 6FE
COMPANY DETAILS
Private company limited by shares registered in England and Wales, registered number 11883125
ACCOUNTANTS
Hope Jones
Chartered Accountants
Suite114, Lymington Town Hall
Avenue Road
Lymington
Hants
SO41 9ZG

Healthcare International Research Limited

ACCOUNTS
FOR THEYEARENDED31 MARCH 2024
CONTENTS
Page
Statement of Financial Position3
Notes to the Accounts4 - 6

Healthcare International Research Limited

STATEMENT OF FINANCIAL POSITION AT31 March 2024
20242023
Notes££
FIXED ASSETS
Tangible assets331,67615,299
Investment assets41011
31,77715,300
CURRENT ASSETS
Stock62,54014,376
Debtors5124,92388,563
Cash at bank and in hand89,1924,171
276,655107,110
CREDITORS: Amounts falling due within one year6156,33280,194
NET CURRENT ASSETS120,32326,916
TOTAL ASSETS LESS CURRENT LIABILITIES152,10042,216
CREDITORS: Amounts falling due after more than one year77,52815,660
NET ASSETS144,57226,556
CAPITAL AND RESERVES
Called up share capital156129
Share premium account1,692,444892,471
Profit and loss account(1,548,028)(866,044)
SHAREHOLDERS' FUNDS144,57226,556
For the year ending 31 March 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors have decided not to deliver to the registrar a copy of the company's profit and loss account.
Approved by the board on12 January 2025and signed on their behalf by
.............................
F A Darver
Director

Healthcare International Research Limited

NOTES TO THE ACCOUNTS
FOR THE YEAR ENDED 31 MARCH 2024
1. ACCOUNTING POLICIES
1a. Basis Of Accounting FRS 1021 a
The accounts have been prepared under the historical cost convention.

The accounts have been prepared in accordance with FRS102 section 1A - The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

The company has taken advantage of the exemption from the requirement to prepare consolidated financial statements as set out in section 399 (2A) of the Companies Act 2006.

1b. Depreciation
Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives.
Websitestraight line 25%
Fixtures, Fittings and Furniturereducing balance 25%
Equipmentstraight line 25%
Motor Bikereducing balance 10%
1c. Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to sell (net realisable value).
1d. Pension Costs
The company operates a defined contribution pension scheme. The pension charge represents the amounts payable by the company to the fund in respect of the year.
1e. Foreign Currency
Transactions in currencies, other than the functional currency of the company, are recorded at the rate of the exchange on the date the transaction occurred. Monetary items denominated in other currencies are translated at the rate prevailing at the end of the reporting period. All differences are taken to the profit and loss account. Non-monetary items that are measured at the historic cost in a foreign currency are not retranslated.
1f. Investment Assets
Fixed asset investments are shown at cost less amounts written off.
Provisions are made for permanent fluctuations in value.
2. EMPLOYEES
20242023
No.No.
Average number of employees22

Healthcare International Research Limited

3. TANGIBLE FIXED ASSETS
Fixtures, Fittings
Websiteand FurnitureEquipmentMotor BikeTotal
£££££
Cost
At 1 April 20237,6056,03711,660-25,302
Additions-5,77611,14110,08327,000
At 31 March 20247,60511,81322,80110,08352,302
Depreciation
At 1 April 20233,5881,5094,906-10,003
For the year1,3392,5765,7001,00810,623
At 31 March 20244,9274,08510,6061,00820,626
Net Book Amounts
At 31 March 20242,6787,72812,1959,07531,676
At 31 March 20234,0174,5286,754-15,299
4. INVESTMENT ASSETS
Shares in group companies
and participating interestsTotal
££
Cost
At 1 April 20235,1095,109
Additions100100
At 31 March 20245,2095,209
Amortisation
At 1 April 20235,1085,108
At 31 March 20245,1085,108
Net Book Amounts
At 31 March 2024101101
At 31 March 202311
5. DEBTORS 20242023
££
Amounts falling due within one year
Trade debtors6,30525,311
VAT59013,247
Other debtors18,4197,850
Amounts due from group companies (net of provision for non-recovery)76,07828,679
Prepayments23,5313,732
Directors current account -9,744
124,92388,563

Healthcare International Research Limited

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
20242023
££
Taxation and social security4,1974,746
Directors current account 165-
Bank Loan4,517-
Loans (note 9)130,70059,666
Trade creditors6,2478,564
Other creditors12789
Accruals10,3797,129
156,33280,194
7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
20242023
££
Bank loan7,52815,660
7,52815,660
8. LOAN TO DIRECTOR
At the beginning of the year, director, F A Darver, owed the company £9,744 on director's current account, interest-free and repayable on demand. This was repaid during the year.
9. POST BALANCE SHEET EVENT
Loans (note 6) include £128,964 (2023 £59,000) received from investors which after the end of the accounting year were used to acquire ordinary shares in the company.